Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 16.
doi: 10.1007/s13730-025-01008-y. Online ahead of print.

Granulomatous interstitial nephritis due to sarcoidosis following SARS-CoV-2 infection: a rare case report

Affiliations
Free article

Granulomatous interstitial nephritis due to sarcoidosis following SARS-CoV-2 infection: a rare case report

Megumi Otani et al. CEN Case Rep. .
Free article

Abstract

We report the first documented case of renal sarcoidosis developing after SARS-CoV-2 infection. The patient, a 59-year-old woman with no significant medical history, was diagnosed with COVID-19 after experiencing persistent fatigue and insomnia. Approximately three weeks after the infection, she developed a skin rash, prompting a biopsy that revealed epithelioid granulomas. A systemic evaluation using computed tomography identified enlarged bilateral hilar lymph nodes, and a needle aspiration biopsy confirmed the presence of epithelioid granulomas, leading to a diagnosis of sarcoidosis. Nine months after recovering from COVID-19, she was referred to the nephrology department due to progressive renal dysfunction. A renal biopsy demonstrated granulomatous interstitial nephritis with Schaumann bodies, consistent with renal sarcoidosis. Treatment with prednisolone (30 mg/day, 0.5 mg/kg/day) resulted in significant improvement in renal function, suggesting a potential link between SARS-CoV-2 infection and immune dysregulation. This case highlights the importance of monitoring renal function in patients with post-COVID-19 sarcoidosis, even in the absence of disease progression in other organs.

Keywords: COVID-19; Interstitial nephritis; SARS-CoV-2; Sarcoidosis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors have declared that no conflicts of interest exist. Informed consent: Informed consent for publication of this report was obtained from the patient. Research involving human participants and/or animals: This article does not contain any studies with animals performed by any of the authors. According to the institutional guidelines, ethics committee approval was not required for this single case report.

Similar articles

References

    1. Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33:155–62. https://doi.org/10.1097/BOR.0000000000000776 . - DOI - PubMed
    1. Garman L, Montgomery CG, Rivera NV. Recent advances in sarcoidosis genomics: epigenetics, gene expression, and gene by environment (G × E) interaction studies. Curr Opin Pulm Med. 2020;26:544–53. https://doi.org/10.1097/MCP.0000000000000719 . - DOI - PubMed - PMC
    1. Sakthivel P, Bruder D. Mechanism of granuloma formation in sarcoidosis. Curr Opin Hematol. 2017;24:59–65. https://doi.org/10.1097/MOH.0000000000000301 . - DOI - PubMed
    1. Broos CE, van Nimwegen M, Hoogsteden HC, Hendriks RW, Kool M, van den Blink B. Granuloma formation in pulmonary sarcoidosis. Front Immunol. 2013;4:437. https://doi.org/10.3389/fimmu.2013.00437 . - DOI - PubMed - PMC
    1. Satoh F, Morita H, Tayama H, Inoue Y, Eishi Y, Yoshimura A. Renal sarcoidosis with limited lung manifestations expressing Propionibacterium acnes antigens in the affected tubulointerstitium. Am J Med Sci. 2013;346:250–2. https://doi.org/10.1097/MAJ.0b013e31828bdf9f . - DOI - PubMed

LinkOut - more resources